MedPath

Effects of Serum Bicarbonate Level on a Decline of Muscle Mass and Strength among Pre-dialysis Chronic Kidney Disease Patients with Metabolic Acidosis: A Randomized Controlled Trial

Phase 4
Recruiting
Conditions
Muscle mass and strength
chronic kidney disease
metabolic acidosis
muscle mass
Registration Number
TCTR20180823003
Lead Sponsor
Ratchadapisek Sompoch Endowment Fund Chulalongkorn University
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
84
Inclusion Criteria

1. CKD stage 3-4 (estimated GFR 15-59 ml/min/m2) patients
2. Serum bicarbonate < 22 mmol/L

Exclusion Criteria

1. Neuromuscular diseases
2. Autoimmune or tranplnted patients who currently receiving immunosuppressive agents (steroids included)
3. Rapidly declining of eGFR
4. Resistant hypertension
5. Fluid overload or heart failure status
6. Morbid obesity (BMI > 35 kg/m2)
7. Patients with cardiac devices

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Change of muscle mass 6 months Mid arm muscle circumference
Secondary Outcome Measures
NameTimeMethod
Change of muscle mass&#44; eGFR 6 months BIA&#44; BIS&#44; serum creatinine
© Copyright 2025. All Rights Reserved by MedPath